BioAge Labs Income Statement (2024-2025) | BIOA

Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 1.45M2.41M2.05M3.08M
Cost of Revenue (Quarter) 4.61M4.68M14.48M13.36M4.63M13.96M12.25M18.62M
Gross Profit (Quarter) -4.61M-4.68M-14.48M-13.36M-3.18M-11.54M-10.19M-15.54M
Operating items
Research & Development (Quarter) 9.32M10.47M20.02M19.23M11.11M19.84M18.51M24.50M
Selling, General & Administrative (Quarter) 3.49M4.80M4.73M6.14M6.79M7.34M6.68M7.00M
Operating Expenses (Quarter) 12.81M15.27M24.75M25.36M17.90M27.18M25.19M31.50M
Operating Income (Quarter) -12.81M-15.27M-24.75M-25.36M-16.45M-24.77M-23.14M-28.42M
EBIT (Quarter) -12.81M-15.27M-24.75M-25.36M-16.45M-24.77M-23.14M-28.42M
Non-operating items
Interest & Investment Income (Quarter) 1.30M2.20M2.04M4.09M3.71M3.42M3.16M2.79M
Other Non Operating Income (Quarter) -0.25M
Non Operating Income (Quarter) -0.18M1.69M1.34M4.23M3.52M3.21M2.97M2.48M
Net income details
EBT (Quarter) -12.73M-13.51M-23.10M-21.59M-12.99M-21.55M-20.13M-25.72M
Profit After Tax (Quarter) -12.99M-13.58M-23.41M-21.13M-12.93M-21.56M-20.17M-25.94M
Income from Continuing Operations (Quarter) -12.73M-13.51M-23.10M-21.59M-12.99M-21.55M-20.13M-25.72M
Consolidated Net Income (Quarter) -12.73M-13.51M-23.10M-21.59M-12.99M-21.55M-20.13M-25.72M
Income towards Parent Company (Quarter) -12.73M-13.51M-23.10M-21.59M-12.99M-21.55M-20.13M-25.72M
Net Income towards Common Stockholders (Quarter) -12.73M-13.51M-23.10M-21.59M-12.99M-21.55M-20.13M-25.72M
Additional items
EPS (Basic) (Quarter) -7.76-7.94-6.7015.13-0.36-0.60-0.56-0.72
EPS (Weighted Average and Diluted) (Quarter) -7.76-7.94-6.7015.13-0.36-0.60-0.56-0.72
Shares Outstanding (Weighted Average) (Quarter) 1.67M1.69M3.49M10.73M35.85M35.85M35.85M35.93M
Shares Outstanding (Diluted Average) (Quarter) 1.67M1.71M2.30M10.73M35.85M35.85M35.85M35.93M
EBITDA (Quarter) -12.97M-13.60M-23.35M-21.10M-12.91M-21.61M-20.11M-25.94M
Interest Expenses (Quarter) 1.22M0.44M0.39M0.32M0.26M0.20M0.15M0.09M